Prof. Paolo Gontero reviews risk stratification for Non-Muscle Invasive Bladder Cancer
Generally speaking, while NMIBCs have a more favourable prognosis compared to their MI counterpart, they are not the same and seem to behave differently (i.e. some are relatively indolent, others have aggressive features).
| Organiser | ESU |
|---|---|
| Duration | 17 min |
In this episode, Prof. Paolo Gontero (IT) explains why this is the case. He will also discuss the following:
- What is the current, best-recommended way for risk stratification of NMIBCs?
- Is there a way to predict the risk of recurrence of an NMIBC?
- How to tailor treatment recommendations
Prof. Paolo Gontero is a member of the EAU Guidelines panel for Non-Muscle Invasive Bladder Cancer
For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates.